Reduced connexin-43 expression, slow conduction and repolarisation dispersion in a model of hypertrophic cardiomyopathy.


Journal

Disease models & mechanisms
ISSN: 1754-8411
Titre abrégé: Dis Model Mech
Pays: England
ID NLM: 101483332

Informations de publication

Date de publication:
01 Aug 2024
Historique:
received: 20 07 2023
accepted: 16 07 2024
medline: 27 8 2024
pubmed: 27 8 2024
entrez: 27 8 2024
Statut: ppublish

Résumé

Hypertrophic cardiomyopathy (HCM) is an inherited heart muscle disease that is characterised by left ventricular wall thickening, cardiomyocyte disarray and fibrosis, and is associated with arrhythmias, heart failure and sudden death. However, it is unclear to what extent the electrophysiological disturbances that lead to sudden death occur secondary to structural changes in the myocardium or as a result of HCM cardiomyocyte electrophysiology. In this study, we used an induced pluripotent stem cell model of the R403Q variant in myosin heavy chain 7 (MYH7) to study the electrophysiology of HCM cardiomyocytes in electrically coupled syncytia, revealing significant conduction slowing and increased spatial dispersion of repolarisation - both well-established substrates for arrhythmia. Analysis of rhythmonome protein expression in MYH7 R403Q cardiomyocytes showed reduced expression of connexin-43 (also known as GJA1), sodium channels and inward rectifier potassium channels - a three-way hit that reduces electrotonic coupling and slows cardiac conduction. Our data represent a previously unreported, biophysical basis for arrhythmia in HCM that is intrinsic to cardiomyocyte electrophysiology. Later in the progression of the disease, these proarrhythmic phenotypes may be accentuated by myocyte disarray and fibrosis to contribute to sudden death.

Identifiants

pubmed: 39189070
pii: 361760
doi: 10.1242/dmm.050407
pii:
doi:

Substances chimiques

Connexin 43 0
Myosin Heavy Chains EC 3.6.4.1
Cardiac Myosins EC 3.6.1.-
MYH7 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Health and Medical Research Council
ID : APP1143321
Organisme : Woodside Energy
Organisme : NSW Health
Organisme : UNSW Sydney

Informations de copyright

© 2024. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interests The authors declare no competing or financial interests.

Auteurs

Seakcheng Lim (S)

Agnes Ginges Centre for Molecular Cardiology at Centenary Institute, The University of Sydney, Sydney 2050, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney 2050, Australia.

Melissa M Mangala (MM)

Victor Chang Cardiac Research Institute, Sydney, 2010, Australia.
School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney 2052, Australia.

Mira Holliday (M)

Agnes Ginges Centre for Molecular Cardiology at Centenary Institute, The University of Sydney, Sydney 2050, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney 2050, Australia.

Henrietta Cserne Szappanos (H)

School of Human Sciences, The University of Western Australia, Crawley 6009, Australia.

Samantha Barratt-Ross (S)

Agnes Ginges Centre for Molecular Cardiology at Centenary Institute, The University of Sydney, Sydney 2050, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney 2050, Australia.

Serena Li (S)

Agnes Ginges Centre for Molecular Cardiology at Centenary Institute, The University of Sydney, Sydney 2050, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney 2050, Australia.

Jordan Thorpe (J)

Victor Chang Cardiac Research Institute, Sydney, 2010, Australia.
School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney 2052, Australia.

Whitney Liang (W)

Victor Chang Cardiac Research Institute, Sydney, 2010, Australia.
School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney 2052, Australia.

Ginell N Ranpura (GN)

Agnes Ginges Centre for Molecular Cardiology at Centenary Institute, The University of Sydney, Sydney 2050, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney 2050, Australia.

Jamie I Vandenberg (JI)

Victor Chang Cardiac Research Institute, Sydney, 2010, Australia.
School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney 2052, Australia.

Christopher Semsarian (C)

Agnes Ginges Centre for Molecular Cardiology at Centenary Institute, The University of Sydney, Sydney 2050, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney 2050, Australia.
Department of Cardiology, Royal Prince Alfred Hospital, Sydney 2050, Australia.

Livia C Hool (LC)

Victor Chang Cardiac Research Institute, Sydney, 2010, Australia.
School of Human Sciences, The University of Western Australia, Crawley 6009, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH